IFI-P · Erucin Series

Specimen SS-F-TRP-381 // PUNGENT · IFI-P

Erucin Series III-PR-A

Brassica nigra

Black Mustard

Tier IIIErucin Series

Target Trait

2.6×

fold-change

Erucin TRPA1 agonist fold-change

Technical Specifications

SKU

SS-F-TRP-381

Genomic Edits

5

GC Content

47.6%

Construct Length

3,270 bp

Promoter System

Ubiquitin / T7

Expression System

Protoplast PEG-fusion

Host Strain

PEG-mediated

Receptor Target

TRPA1

IFI Score

260

Pathway Edits

  • GSTU20 (glutathione S-transferase) upregulation for glucoerucin biosynthesis and TRPA1-active erucin formation
  • MAM3 (methylthioalkylmalate synthase 3) overexpression for 4-methylthiobutyl glucosinolate chain elongation
  • CYP79F1 upregulation for long-chain aliphatic glucosinolate oxime synthesis from homomethionine
  • FMOGS-OX1-null allele introduction to prevent glucoerucin oxidation to sulforaphane-analog branch
  • TGG1 myrosinase optimization for glucoerucin hydrolysis and free erucin release kinetics

Key Interventions

MAM3/CYP79F1 chain-elongation pathway amplification for glucoerucin pool expansion in Brassica nigraFMOGS-OX1-null allele preserves glucoerucin in the reduced thioether form for selective erucin ITC formation via TGG1 myrosinaseErucin TRPA1 electrophilic agonism confirmed by IFI-P calcium-flux assay; erucin isothiocyanate targets TRPA1 Cys621 for covalent channel activationPEG-mediated transient expression protocol validated for rapid phenotypic pathway screening

IFI Subscale Profile

IFI Profile

IFI-S
—
IFI-U
—
IFI-B
—
IFI-K
—
IFI-C
—
IFI-P
260
IFI-A
—
IFI-F
—

Use Case

Tier III erucin-enriched Brassica platform for sulfurous-ITC flavor applications in mustard condiments, cooked brassica flavor development, and TRPA1-selective functional ingredient production where erucin's milder, less volatile profile relative to AITC is preferred for thermal stability in hot-processed food applications.

License

$1499 · Tier III License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?

Back to Pungent · IFI-PAll Modalities